Purchases and Sales Made in Q1 2024 in Sangamo Therapeutics, Inc (SGMO)
This table provides information about the institutional ownership of Sangamo Therapeutics, Inc (SGMO) during Q1 2024. The information is specifically focused on institutions that hold shares of SANGAMO THERAPEUTICS, INC.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 15, 2024
Q1 2024
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-657K- 31.51% |
$276K - $907K
|
1.43M
$1.24M
|
|
May 03, 2024
Q1 2024
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-711K- 66.13% |
$299K - $982K
|
364K
$317K
|
|
May 15, 2024
Q1 2024
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
SELL
|
- |
-816K- 80.96% |
$343K - $1.13M
|
192K
$167K
|
|
May 10, 2024
Q1 2024
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-818K- 5.8% |
$344K - $1.13M
|
13.3M
$11.6M
|
|
May 15, 2024
Q1 2024
|
Hudson Bay Capital Management LP
Greenwich, CT |
SELL
|
- |
-1.13M- 45.06% |
$473K - $1.55M
|
1.37M
$1.19M
|
|
May 15, 2024
Q1 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-1.18M- 95.79% |
$495K - $1.63M
|
51.9K
$45.1K
|
|
May 15, 2024
Q1 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-1.62M- 34.51% |
$679K - $2.23M
|
3.07M
$2.67M
|
|
May 15, 2024
Q1 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-1.62M- 74.48% |
$680K - $2.23M
|
555K
$483K
|